Welcome to our dedicated page for Cimpress Plc SEC filings (Ticker: CMPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cimpress plc filings document the Irish public company's financial reporting, material events, capital structure and shareholder governance. Recent Form 8-K reports furnish quarterly earnings documents for fiscal periods, record material-event disclosures and describe capital-allocation actions such as ordinary share repurchase authorizations.
Proxy filings for Cimpress cover annual general meeting matters, board reappointments, shareholder voting items and governance procedures. The filing record also provides formal disclosure around material agreements, operating and financial results, ordinary-share capital matters and other events relevant to its web-to-print mass-customization business.
Cimpress plc reported via Form 8-K that on October 29, 2025 it posted its Q1 Fiscal Year 2026 Quarterly Earnings Document, discussing results for the quarter ended September 30, 2025. The full text is furnished as Exhibit 99.1.
The company states this information and exhibit are furnished, not filed, and are not subject to Section 18 liability, nor incorporated by reference except as expressly set forth by specific reference.
Cimpress plc (CMPR) filed its definitive proxy for the 2025 Annual General Meeting to be held on December 17, 2025 at 6:00 p.m. Dublin Time in Dublin. Shareholders will vote to reappoint Robert S. Keane and Scott J. Vassalluzzo to three-year terms, hold an advisory vote on executive compensation, reappoint PricewaterhouseCoopers Ireland as statutory auditor, and authorize the Board or Audit Committee to set PwC’s remuneration. Shareholders of record on October 16, 2025 may vote; proxies are due by 11:59 p.m. Eastern Time on December 16, 2025.
Capital authorities: Proposal 4 seeks to renew authority to issue up to 4,934,357 ordinary shares (20% of issued and outstanding) until June 17, 2027. Proposal 5 seeks a matching opt-out from Irish statutory preemption rights for cash issuances up to the same 20% limit; it requires a special resolution with at least 75% of votes cast, while others require a simple majority. The filing also outlines FY25 performance share units, including a 60% minimum payout multiplier, a CEO pay ratio of 1-to-360, and FY2025 PwC fees of $4,917,000.
Cimpress (CMPR) executive Florian Baumgartner reported equity transactions on 10/15/2025. 1,025 ordinary shares were acquired upon RSU vesting (code M) at $0, and 487 shares were disposed (code F) at $64.18 for tax withholding. After these transactions, he holds 56,431 ordinary shares directly and 5,128 RSUs.
The RSUs vest over four years: 25% on the initial vesting date and 6.25% quarterly thereafter.
Cimpress plc director Dessislava Temperley reported insider transactions on 09/15/2025. 435 restricted share units (RSUs) vested and converted into 435 ordinary shares at no cash cost, increasing her holdings to 3,139 ordinary shares. On the same date she disposed of 209 ordinary shares at an average price of $57.10 per share, leaving her with 2,930 shares after the sale. The RSUs referenced were part of a grant that began vesting on 09/15/2022 and vest over four years (25% at the initial vesting date and 25% annually thereafter). The Form 4 was signed by an attorney-in-fact on 09/16/2025.
Insider transactions at Cimpress plc (CMPR): Robert S. Keane, CEO and Chairman, reported multiple automatic vestings of performance share units (PSUs) and a subsequent open-market sale on 08/15/2025. PSUs converted to ordinary shares at $0 per unit as they vested, increasing his beneficial ownership across several tranches. Following the vestings, Mr. Keane sold 8,455 ordinary shares at a price of $60.16 each, reducing his beneficial ownership to 57,383 shares. The filing shows the structure and vesting schedules for the PSUs, including staggered vesting dates through 08/15/2028 and the initial exercisability dates in 2024 and 2025.
Florian Baumgartner, EVP and CEO, Vista, reported multiple automatic vesting transactions in Cimpress plc (CMPR) on 08/15/2025. Restricted share units (RSUs) and performance share units (PSUs) vested, resulting in non‑derivative acquisitions of 934, 1,691, 3,550 and 5,212 ordinary shares (all recorded as Code M, $0 price) and derivative entries showing the underlying RSUs/PSUs and their vesting schedules. Following the vesting, Baumgartner beneficially owned between 50,848 and 61,301 ordinary shares across the lines reported. Separately, he disposed of 5,408 ordinary shares at $60.16 each, leaving reported holdings reflected in Table I and Table II. The Form 4 was signed by an attorney‑in‑fact on 08/15/2025.
Maarten Wensveen, EVP & Chief Technology Officer of Cimpress plc (CMPR), reported multiple equity award vestings and one open-market sale on 08/15/2025. Several restricted share units (RSUs) and performance share units (PSUs) vested, resulting in automatic acquisitions of ordinary shares at $0 per share: 2,337 RSUs, 1,860 RSUs, 3,697 PSUs and 5,212 PSUs were recorded as acquired. On the same date he sold 5,695 ordinary shares at $60.16 each. Following these transactions, Wensveen beneficially owns 43,417 ordinary shares and holds vested and unvested derivative awards reflected in Table II. The filings note standard multi-year vesting schedules for RSUs and PSUs.
Sean E. Quinn, EVP & Chief Financial Officer of Cimpress plc (CMPR), reported multiple equity transactions on 08/15/2025. Several restricted share units (RSUs) and performance share units (PSUs) vested or were recorded as acquired: 2,804 RSUs, 2,300 RSUs, 4,570 PSUs and 6,602 PSUs, each shown as acquired at $0 reflecting vesting or issuance terms. Following the transactions, Quinn beneficially owned between 26,884 and 40,356 ordinary shares across different line items. Separately, 7,872 ordinary shares were disposed of at a price of $60.16 per share. The Form 4 explains RSU and PSU vesting schedules and that each unit represents Cimpress' commitment to issue one ordinary share when vested or earned.
Janus Henderson Group plc and its Janus Henderson Enterprise Fund report substantial beneficial interests in Cimpress PLC common stock on this Schedule 13G/A. Janus Henderson Group discloses shared voting and dispositive power over 3,315,908 shares, representing 13.3% of the class, with no sole voting or dispositive power. The Janus Henderson Enterprise Fund reports shared voting and dispositive power over 2,355,405 shares, representing 9.5% of the class. The filing states these holdings are held in the ordinary course of business and not for the purpose of changing or influencing control. The filing also identifies indirect subsidiaries (JHIUS, JHIUKL, JHIAIFML) as registered investment advisers providing advice to managed portfolios.
Cimpress plc (CMPR) reported that Robert S. Keane, its CEO and Chairman, was granted performance share units (PSUs) tied to fiscal 2025 results. The Compensation Committee determined on 08/07/2025 the number of shares issuable under two PSU awards originally granted on 08/15/2024: 54,204 PSUs for his CEO role and 1,390 PSUs for his board role, with each PSU representing a commitment to issue one ordinary share.
These PSUs are performance-based using revenue, adjusted EBITDA, and unlevered free cash flow for the year ended 06/30/2025 and are reported as direct beneficial ownership. The PSUs vest over four years (25% on the date exercisable and 6.25% quarterly thereafter) with the first exercisable date shown as 08/15/2025 and an expiration date of 08/15/2028.